Literature DB >> 21658796

A review of DRESS-associated myocarditis.

Greg P Bourgeois1, Jennifer A Cafardi, Vlada Groysman, Lauren C Hughey.   

Abstract

DRESS (drug rash with eosinophilia and systemic symptoms), also known as drug-induced hypersensitivity syndrome, is a severe, systemic drug reaction most commonly associated with aromatic anticonvulsants and sulfonamides. Patients typically present with fever, facial edema, cervical lymphadenopathy and a morbilliform eruption, which may progress to erythroderma. Hematologic abnormalities are a hallmark of the condition, including eosinophilia and atypical lymphocytosis. Visceral organ involvement typically manifests as hepatic dysfunction but may include lymphadenopathy, nephritis, interstitial pneumonitis, and myocarditis. Five to ten percent of patients with DRESS die from systemic complications, making timely recognition and treatment essential to prevent life-threatening manifestations. Myocarditis is a fatal and under-recognized manifestation of DRESS, which may occur long after the initial diagnosis. We review the literature of previously reported cases of DRESS and myocardial involvement, highlighting the presenting symptoms associated with cardiac involvement, treatments used, and the outcome for each patient. In addition, we offer an algorithm for early diagnosis, treatment, and subsequent monitoring of these patients.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21658796     DOI: 10.1016/j.jaad.2010.11.057

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  25 in total

1.  Fulminant necrotizing eosinophilic myocarditis after COVID-19 vaccination survived with mechanical circulatory support.

Authors:  Mitsukuni Kimura; Toru Hashimoto; Eri Noda; Yusuke Ishikawa; Akihito Ishikita; Takeo Fujino; Shouji Matsushima; Tomomi Ide; Shintaro Kinugawa; Kazuhiro Nagaoka; Tomoki Ushijima; Akira Shiose; Hiroyuki Tsutsui
Journal:  ESC Heart Fail       Date:  2022-05-26

2.  Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.

Authors:  Natsumi Hama; Riichiro Abe; Andrew Gibson; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2022-02-15

3.  Acute eosinophilic myocarditis with dramatic response to steroid therapy: the central role of echocardiography in diagnosis and follow-up.

Authors:  Manuela Eppenberger; Dietrich Hack; Peter Ammann; Hans Rickli; Micha T Maeder
Journal:  Tex Heart Inst J       Date:  2013

4.  A fatal case of DRESS induced by strontium ranelate associated with HHV-7 reactivation.

Authors:  F Drago; L Cogorno; F Broccolo; G Ciccarese; A Parodi
Journal:  Osteoporos Int       Date:  2015-10-30       Impact factor: 5.071

Review 5.  Myocarditis: A Clinical Overview.

Authors:  A L P Caforio; G Malipiero; R Marcolongo; S Iliceto
Journal:  Curr Cardiol Rep       Date:  2017-07       Impact factor: 3.955

6.  DRESS syndrome associated with type 2 diabetes in a child.

Authors:  Semiha Bahceci Erdem; Hikmet Tekin Nacaroglu; Ozlem Bag; Canan Sule Unsal Karkiner; Huseyin Anil Korkmaz; Demet Can
Journal:  Cent Eur J Immunol       Date:  2016-01-15       Impact factor: 2.085

Review 7.  Drug induced exfoliative dermatitis: state of the art.

Authors:  Mona-Rita Yacoub; Alvise Berti; Corrado Campochiaro; Enrico Tombetti; Giuseppe Alvise Ramirez; Andrea Nico; Elisabetta Di Leo; Paola Fantini; Maria Grazia Sabbadini; Eustachio Nettis; Giselda Colombo
Journal:  Clin Mol Allergy       Date:  2016-08-22

8.  Fatal sulfasalazine-induced eosinophilic myocarditis in a patient with periodic fever syndrome.

Authors:  Ivica Jeremic; Nada Vujasinovic-Stupar; Tatjana Terzic; Nemanja Damjanov; Milos Nikolic; Branka Bonaci-Nikolic
Journal:  Med Princ Pract       Date:  2014-12-16       Impact factor: 1.927

Review 9.  [Vasculitides and eosinophilic pulmonary diseases].

Authors:  C Kroegel; M Foerster; S Quickert; H Slevogt; T Neumann
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.834

10.  [Vasculitides and eosinophilic pulmonary diseases].

Authors:  C Kroegel; M Foerster; S Quickert; H Slevogt; T Neumann
Journal:  Z Rheumatol       Date:  2018-12       Impact factor: 1.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.